EUCRW
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
EUCRW
Delisted
EUCRW was delisted on the 26th of April, 2023.
25 hedge funds and large institutions have $1.08M invested in Eucrates Biomedical Acquisition Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
25
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$1.85K | |
| 2 | +$1.45K | |
| 3 | +$1.26K | |
| 4 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$1K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$891 |
Top Sellers
| 1 | -$7.47K | |
| 2 | -$6K | |
| 3 | -$5K | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.75K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1K |